China Cord Blood Corp. (NYSE:CO) shares saw strong trading volume on Friday . 77,832 shares were traded during trading, an increase of 47% from the previous session’s volume of 52,954 shares.The stock last traded at $5.46 and had previously closed at $5.55.

Separately, Zacks Investment Research upgraded shares of China Cord Blood Corp. from a “hold” rating to a “buy” rating and set a $6.75 price target for the company in a report on Thursday, March 24th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. China Cord Blood Corp. presently has an average rating of “Buy” and a consensus price target of $8.33.

The company has a market capitalization of $399.33 million and a P/E ratio of 29.25. The firm’s 50-day moving average is $5.90 and its 200-day moving average is $6.04.

China Cord Blood Corp. (NYSE:CO) last issued its quarterly earnings data on Tuesday, June 14th. The company reported $0.03 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.03. The business earned $24.30 million during the quarter. On average, equities analysts expect that China Cord Blood Corp. will post $0.17 EPS for the current fiscal year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.